Table of Content

1.Biopharmaceuticals Contract Manufacturing Market Report Introduction
2.Biopharmaceuticals Contract Manufacturing Market Executive summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis
3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Biopharmaceuticals Contract Manufacturing Market Key factors analysis
4.1. Biopharmaceuticals Contract Manufacturing Market Drivers
4.1.1. The rising burden of various chronic diseases such as cancer, cardiovascular related
4.1.2. The growing R&D investments for the development of various biologics and biosimilars
4.1.3. The rise in the volume of outsourcing by the key biopharma giants
4.1.4. Advantages associated with CMOs in streamlining the drug development & manufacturing process
4.2. Biopharmaceuticals Contract Manufacturing Market Restraints and Challenges
4.2.1. The high cost of setting up a production facility for biopharmaceuticals
4.2.2. The regulatory hurdle for CMOs in gaining product approval
4.3. Biopharmaceuticals Contract Manufacturing Market Opportunities
4.3.1. Strategic business activities by CMOs for expanding their services in biopharmaceutical development & manufacturing

5. Biopharmaceuticals Contract Manufacturing Porter’s Five Forces Analysis
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Biopharmaceuticals Contract Manufacturing Market

7. Biopharmaceuticals Contract Manufacturing Market layout
7.1. By Product
7.1.1. Biologics
7.1.1.1. Monoclonal antibodies (MABs)
7.1.1.2. Proteins/Peptides
7.1.1.3. Vaccines
7.1.1.4. Others
7.1.2. Biosimilars
7.2. By Source
7.2.1. Mammalian
7.2.2. Non-Mammalian
7.3. By Geography
7.3.1. North America
7.3.1.1. United States
7.3.1.2. Canada
7.3.1.3. Mexico
7.3.2. Europe
7.3.2.1. France
7.3.2.2. Germany
7.3.2.3. United Kingdom
7.3.2.4. Italy
7.3.2.5. Spain
7.3.2.6. Russia
7.3.2.7. Rest of Europe
7.3.3. Asia-Pacific
7.3.3.1. China
7.3.3.2. Japan
7.3.3.3. India
7.3.3.4. Australia
7.3.3.5. South Korea
7.3.3.6. Rest of Asia Pacific
7.3.4. Rest of the World (RoW)
7.3.4.1. Middle East
7.3.4.2. Africa
7.3.4.3. South America

8. Biopharmaceuticals Contract Manufacturing Global Company Share Analysis – Key 3-5 Companies

9. Biopharmaceuticals Contract Manufacturing Company and Product Profiles
9.1. Boehringer Ingelheim International GmbH
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4. Product Listing
9.1.5. Entropy
9.2. Lonza
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Financial Overview
9.2.4. Product Listing
9.2.5. Entropy
9.3. Rentschler Biopharma SE
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Financial Overview
9.3.4. Product Listing
9.3.5. Entropy
9.4. BINEX Co., Ltd.
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Financial Overview
9.4.4. Product Listing
9.4.5. Entropy
9.5. INCOG BioPharma Service
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Financial Overview
9.5.4. Product Listing
9.5.5. Entropy
9.6. FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Financial Overview
9.6.4. Product Listing
9.6.5. Entropy
9.7. Novartis AG
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Financial Overview
9.7.4. Product Listing
9.7.5. Entropy
9.8. ProBioGen AG
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Financial Overview
9.8.4. Product Listing
9.8.5. Entropy
9.9. TOYOBO CO., LTD.
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Financial Overview
9.9.4. Product Listing
9.9.5. Entropy
9.10. Samsung Biologics
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Financial Overview
9.10.4. Product Listing
9.10.5. Entropy
9.11. Thermo Fisher Scientific, Inc.
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Financial Overview
9.11.4. Product Listing
9.11.5. Entropy
9.12. AbbVie, Inc.
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Financial Overview
9.12.4. Product Listing
9.12.5. Entropy
9.13. WuXi Biologics
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Financial Overview
9.13.4. Product Listing
9.13.5. Entropy
9.14. AGC Biologics
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Financial Overview
9.14.4. Product Listing
9.14.5. Entropy
9.15. ADMA Biologics, Inc.
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Financial Overview
9.15.4. Product Listing
9.15.5. Entropy
9.16. Baxter BioPharma Solutions (Baxter)
9.16.1. Company Overview
9.16.2. Company Snapshot
9.16.3. Financial Overview
9.16.4. Product Listing
9.16.5. Entropy
9.17. iBio.
9.17.1. Company Overview
9.17.2. Company Snapshot
9.17.3. Financial Overview
9.17.4. Product Listing
9.17.5. Entropy
9.18. Catalent, Inc.
9.18.1. Company Overview
9.18.2. Company Snapshot
9.18.3. Financial Overview
9.18.4. Product Listing
9.18.5. Entropy
9.19. Cambrex Corporation
9.19.1. Company Overview
9.19.2. Company Snapshot
9.19.3. Financial Overview
9.19.4. Product Listing
9.19.5. Entropy
9.20. Pfizer Inc.
9.20.1. Company Overview
9.20.2. Company Snapshot
9.20.3. Financial Overview
9.20.4. Product Listing
9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us



List of Figures

Figure 1: Competitive Analysis
Figure 2: COVID-19 Impact Analysis on Biopharmaceuticals Contract Manufacturing Market
Figure 3: Biopharmaceuticals Contract Manufacturing Market Analysis in Global (2019-2027)
Figure 4: Biopharmaceuticals Contract Manufacturing Market Analysis in Global by Product (2019-2027)
Figure 5: Biopharmaceuticals Contract Manufacturing Market Analysis in Global by Source (2019-2027)
Figure 6: Biopharmaceuticals Contract Manufacturing Market Analysis in Global by Geography (2019-2027)
Figure 7: Biopharmaceuticals Contract Manufacturing Market Analysis in North America (2019-2027)
Figure 8: Biopharmaceuticals Contract Manufacturing Market Analysis in North America by Country (2019-2027)
Figure 9: Biopharmaceuticals Contract Manufacturing Market Analysis in the US (2019-2027)
Figure 10: Biopharmaceuticals Contract Manufacturing Market Analysis in Canada (2019-2027)
Figure 11: Biopharmaceuticals Contract Manufacturing Market Analysis in Mexico (2019-2027)
Figure 12: Biopharmaceuticals Contract Manufacturing Market Analysis in Europe (2019-2027)
Figure 13: Biopharmaceuticals Contract Manufacturing Market Analysis in Europe by Country (2019-2027)
Figure 14: Biopharmaceuticals Contract Manufacturing Market Analysis in France (2019-2027)
Figure 15: Biopharmaceuticals Contract Manufacturing Market Analysis in Germany (2019-2027)
Figure 16: Biopharmaceuticals Contract Manufacturing Market Analysis in the UK (2019-2027)
Figure 17: Biopharmaceuticals Contract Manufacturing Market Analysis in Italy (2019-2027)
Figure 18: Biopharmaceuticals Contract Manufacturing Market Analysis in Spain (2019-2027)
Figure 19: Biopharmaceuticals Contract Manufacturing Market Analysis in Russia (2019-2027)
Figure 20: Biopharmaceuticals Contract Manufacturing Market Analysis in Rest of Europe (2019-2027)
Figure 21: Biopharmaceuticals Contract Manufacturing Market Analysis in Asia-Pacific (2019-2027)
Figure 22: Biopharmaceuticals Contract Manufacturing Market Analysis in Asia-Pacific by Country (2019-2027)
Figure 23: Biopharmaceuticals Contract Manufacturing Market Analysis in China (2019-2027)
Figure 24: Biopharmaceuticals Contract Manufacturing Market Analysis in Japan (2019-2027)
Figure 25: Biopharmaceuticals Contract Manufacturing Market Analysis in India (2019-2027)
Figure 26: Biopharmaceuticals Contract Manufacturing Market Analysis in Australia (2019-2027)
Figure 27: Biopharmaceuticals Contract Manufacturing Market Analysis in South Korea (2019-2027)
Figure 28: Biopharmaceuticals Contract Manufacturing Market Analysis in Rest of Asia-Pacific (2019-2027)
Figure 29: Biopharmaceuticals Contract Manufacturing Market Analysis in Rest of World (2019-2027)
Figure 30: Biopharmaceuticals Contract Manufacturing Market Analysis in Rest of World by Region (2019-2027)
Figure 31: Biopharmaceuticals Contract Manufacturing Market Analysis in the Middle East (2019-2027)
Figure 32: Biopharmaceuticals Contract Manufacturing Market Analysis in Africa (2019-2027)
Figure 33: Biopharmaceuticals Contract Manufacturing Market Analysis in South America (2019-2027)
Figure 34: Market Drivers
Figure 35: Market Barriers
Figure 36: Market Opportunities
Figure 37: PORTER’s Five Force Analysis

List of Tables

Table 1: Competitive Analysis
Table 2: COVID-19 Impact Analysis on Biopharmaceuticals Contract Manufacturing Market
Table 3: Biopharmaceuticals Contract Manufacturing Market Analysis in Global (2019-2027)
Table 4: Biopharmaceuticals Contract Manufacturing Market Analysis in Global by Product (2019-2027)
Table 5: Biopharmaceuticals Contract Manufacturing Market Analysis in Global by Source (2019-2027)
Table 6: Biopharmaceuticals Contract Manufacturing Market Analysis in Global by Geography (2019-2027)
Table 7: Biopharmaceuticals Contract Manufacturing Market Analysis in North America (2019-2027)
Table 8: Biopharmaceuticals Contract Manufacturing Market Analysis in North America by Country (2019-2027)
Table 9: Biopharmaceuticals Contract Manufacturing Market Analysis in the US (2019-2027)
Table 10: Biopharmaceuticals Contract Manufacturing Market Analysis in Canada (2019-2027)
Table 11: Biopharmaceuticals Contract Manufacturing Market Analysis in Mexico (2019-2027)
Table 12: Biopharmaceuticals Contract Manufacturing Market Analysis in Europe (2019-2027)
Table 13: Biopharmaceuticals Contract Manufacturing Market Analysis in Europe by Country (2019-2027)
Table 14: Biopharmaceuticals Contract Manufacturing Market Analysis in France (2019-2027)
Table 15: Biopharmaceuticals Contract Manufacturing Market Analysis in Germany (2019-2027)
Table 16: Biopharmaceuticals Contract Manufacturing Market Analysis in the UK (2019-2027)
Table 17: Biopharmaceuticals Contract Manufacturing Market Analysis in Italy (2019-2027)
Table 18: Biopharmaceuticals Contract Manufacturing Market Analysis in Spain (2019-2027)
Table 19: Biopharmaceuticals Contract Manufacturing Market Analysis in Russia (2019-2027)
Table 20: Biopharmaceuticals Contract Manufacturing Market Analysis in Rest of Europe (2019-2027)
Table 21: Biopharmaceuticals Contract Manufacturing Market Analysis in Asia-Pacific (2019-2027)
Table 22: Biopharmaceuticals Contract Manufacturing Market Analysis in Asia-Pacific by Country (2019-2027)
Table 23: Biopharmaceuticals Contract Manufacturing Market Analysis in China (2019-2027)
Table 24: Biopharmaceuticals Contract Manufacturing Market Analysis in Japan (2019-2027)
Table 25: Biopharmaceuticals Contract Manufacturing Market Analysis in India (2019-2027)
Table 26: Biopharmaceuticals Contract Manufacturing Market Analysis in Australia (2019-2027)
Table 27: Biopharmaceuticals Contract Manufacturing Market Analysis in South Korea (2019-2027)
Table 28: Biopharmaceuticals Contract Manufacturing Market Analysis in Rest of Asia-Pacific (2019-2027)
Table 29: Biopharmaceuticals Contract Manufacturing Market Analysis in Rest of World (2019-2027)
Table 30: Biopharmaceuticals Contract Manufacturing Market Analysis in Rest of World by Region (2019-2027)
Table 31: Biopharmaceuticals Contract Manufacturing Market Analysis in the Middle East (2019-2027)
Table 32: Biopharmaceuticals Contract Manufacturing Market Analysis in Africa (2019-2027)
Table 33: Biopharmaceuticals Contract Manufacturing Market Analysis in South America (2019-2027)